About US
Contact us
-
Novartis' pay-for-performance Entresto plan has its critics--Express Scripts' Miller among themNovartis ($NVS) has said it's planning to offer an outcomes-based plan for its new blockbuster-in-the-making to secure payers' favor. But skeptics see some kinks in the plan--and the CMO at leading PB2015/7/13
-
CFDA issues Measures for Unannounced Inspection of Drugs and Medical DevicesChina Food and Drug Administration (CFDA) recently issued the Measures for Unannounced Inspection of Drugs and Medical Devices, which will be implemented as of September 1, 2015. The Measures comprise2015/7/10
-
Glaxo's HIV unit ViiV aims to steal share from Gilead before patents biteGlaxoSmithKline's ($GSK)ViiV Healthcarestole the show in Q1, surpassing analyst expectations and prompting the pharma to hang on to theHIVdrug business, canceling all plans for a potential spinoff. Th2015/7/10
-
Fresenius companies fined £550,000 by U.K. court in patient deathFresenius Kabiand a sister company were ordered by a U.K. court on Thursday to pay more than $860,000 in penalties after a diabetic patient died because the syringes the companies supplied contained n2015/7/10
-
CFDA issues announcement on record filing of clinical trials of medical devicesIn order to standardize the record filing of clinical trials of medical devices and enhance the supervision and management of medical device clinical trials, China Food and Drug Administration (CFDA)2015/7/9
-
AZ's Bydureon tops doc-payments list with $22BWhen it comes to which brands spent the most on doctor payments, 2014 crowned a new king--and that's diabetes drugBydureon. Maker AstraZeneca ($AZN) shelled out $22 million, helping the med eclipse No2015/7/9
-
Maryland Rep joins chorus of Amphastar critics, urging OD drug price dealAmphastar ($AMPH) is in hot water with U.S. officials again. After New York and other states put the squeeze on the company to drop the price of its overdose drug, naloxone, Rep. Elijah Cummings of Ma2015/7/9
-
Mylan didn't disclose director's ties to HQ land deal: WSJBack in late 2013, Mylan ($MYL) moved into a new headquarters in an office park near Pittsburgh--a 5-story building for about 700 employees. The main developer of that office park? Company Vice Chair2015/7/8
-
Novartis nabs early FDA approval for 'megablockbuster' EntrestoIt was a hotly anticipated pipeline drug. Now, Novartis' heart failure remedy Entresto is a hot new approval. The FDA gave its blessing 6 weeks early, and now the former LCZ696 can get ready to roll.2015/7/8
-
CFDA issues Good Supply Practice for Pharmaceutical Products (CFDA Order No. 13)The Good Supply Practice for Pharmaceutical Products (CFDA Order No. 13) was adopted at the executive meeting of China Food and Drug Administration (CFDA) on May 18, 2015, and was recently promulgated2015/7/7